Clinical Trial Update: Multicenter Randomized Double-blind Study Evaluating the Effects of Botulinum Toxin A Associated With ropivacaïne Versus ropivacaïne Alone in the Treatment of the Myofascial Pelviperineal Pain [Phase 3]

View source ↗

Summary

A Phase 3 multicenter randomized double-blind trial comparing botulinum toxin A plus ropivacaine versus ropivacaine alone for myofascial pelviperineal pain has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pelviperineal Pain

Drugs mentioned

• Botulinum toxin A (botulinum toxin type A)
• Ropivacaine (Ropivacaine)

Snippet

Sponsor: Nantes University Hospital | Conditions: Myofascial Pelviperineal Pain | Phase 3 | Status: COMPLETED